Current options in treatment of anthracycline-resistant breast cancer

This publication has 73 references indexed in Scilit:

• Epirubicin
  Drugs, 1997
• Dose Intensity of Chemotherapy in Breast Cancer. Results of Clinical Studies
  Oncology Research and Treatment, 1995
• Co-amplification of erbB2, topoisomerase II α and retinoic acid receptor α genes in breast cancer and allelic loss at topoisomerase I on chromosome 20
  European Journal Of Cancer, 1993
• A phase II study with mitomycin and vindesine in metastatic pretreated breast cancer
  European Journal of Cancer and Clinical Oncology, 1991
• Bepridil in combination with anthracyclines to reverse anthracycline resistance in cancer patients
  European Journal of Cancer and Clinical Oncology, 1991
• Continuous 5-fluorouracil infusion in refractory carcinoma of the breast
  Breast Cancer Research and Treatment, 1987
• Cisplatin plus vindesine in advanced breast cancer: a phase II trial of the EORTC breast cancer coooperative group
  European Journal of Cancer and Clinical Oncology, 1985
• Vindesine in the treatment of metastatic breast cancer
  European Journal of Cancer and Clinical Oncology, 1984
• Increasing therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology
  Pharmacology & Therapeutics, 1983
• Integration of chemotherapy into combined modality treatment of solid tumors: VII. Adenocarcinoma of the breast
  Cancer Treatment Reviews, 1976